Targeted Correction of the Human p-globin Gene. The ability to genetically manipulate human stem cells has the potential to enhance the utility of stem cell therapy for human disease. One emerging approach to targeted genome modification is the use of triplex- forming oligonucleotides (TFOs). These molecules bind to duplex DNA in a sequence-specific manner, and this binding can be used to stimulate recombination and gene correction in mammalian cells. Initial work by our group and others has demonstrated that TFOs can stimulate recombination either by delivering a tethered psoralen adduct or by the ability of triple helices, themselves, to provoke DNA repair and thereby sensitize the target site to recombination. Using a series of chemical modifications, the intracellular effectiveness of TFOs has been progressively enhanced. In this revised A2 application, we propose to develop specific TFOs and TFO analogs such as peptide nucleic acids (PNAs) for intracellular binding to the human (3-globin gene with the intention of ultimately generating an optimized reagent set for molecular correction of mutations associated with thalassemia and sickle cell anemia. We will test promising TFOs or PNAs and donor DNA molecules for the ability to correct (3-globin mutations using specially designed reporter systems in cell lines in culture. New data now demonstrate our ability to target the (3-globin gene in human cells with modified TFOs. Gene correction in mouse hematopoietic stem cells (HSCs) will be studied in cells derived from transgenic mice engineered to incorporate human p-globin gene sequences in the context of a green fluorescent protein (GFP) reporter gene. We will also test targeting of the p-globin gene in primary human CD34+ cells enriched for HSCs in assays for both TFO-targeted psoralen crosslinks and for the generation of a targeted sequence change within the p-globin gene. In this revised application, continued optimization of transfection techniques in hematopoietic stem cells and new strategies to boost gene correction frequencies will enhance these efforts. The overall hypothesis driving this application is that high-affinity, site-specific DNA binding by TFOs can be used as a tool to stimulate gene targeting in stem cells. Our long-range goal is to develop such molecules as reagents for targeted genome modification of disease-related genes in human cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL082655-04
Application #
7911748
Study Section
Special Emphasis Panel (ZRG1-GTIE-A (01))
Program Officer
Qasba, Pankaj
Project Start
2007-09-01
Project End
2012-07-31
Budget Start
2010-08-01
Budget End
2012-07-31
Support Year
4
Fiscal Year
2010
Total Cost
$412,664
Indirect Cost
Name
Yale University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
McNeer, Nicole Ali; Anandalingam, Kavitha; Fields, Rachel J et al. (2015) Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nat Commun 6:6952
Reza, Faisal; Glazer, Peter M (2015) Therapeutic genome mutagenesis using synthetic donor DNA and triplex-forming molecules. Methods Mol Biol 1239:39-73
Reza, Faisal; Glazer, Peter M (2014) Triplex-mediated genome targeting and editing. Methods Mol Biol 1114:115-42
Schleifman, Erica B; Glazer, Peter M (2014) Peptide nucleic acid-mediated recombination for targeted genomic repair and modification. Methods Mol Biol 1050:207-22
Chin, Joanna Y; Reza, Faisal; Glazer, Peter M (2013) Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells. Mol Ther 21:580-7
McNeer, N A; Schleifman, E B; Cuthbert, A et al. (2013) Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther 20:658-69
Rogers, Faye A; Lin, Sharon S; Hegan, Denise C et al. (2012) Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate. Mol Ther 20:109-18
McNeer, Nicole A; Chin, Joanna Y; Schleifman, Erica B et al. (2011) Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Mol Ther 19:172-80
McNeer, Nicole Ali; Schleifman, Erica B; Glazer, Peter M et al. (2011) Polymer delivery systems for site-specific genome editing. J Control Release 155:312-6
Schleifman, Erica B; Bindra, Ranjit; Leif, Jean et al. (2011) Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem Biol 18:1189-98

Showing the most recent 10 out of 13 publications